ReviewDegenerative neurological and neuromuscular disease2012

Emerging oral immunomodulating agents - focus on teriflunomide for the treatment of multiple sclerosis.

Enyioma Nwankwo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.